Correlation Between Procter Gamble and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Procter Gamble and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procter Gamble and AN2 Therapeutics, you can compare the effects of market volatilities on Procter Gamble and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and AN2 Therapeutics.
Diversification Opportunities for Procter Gamble and AN2 Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Procter and AN2 is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Procter Gamble i.e., Procter Gamble and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Procter Gamble and AN2 Therapeutics
Allowing for the 90-day total investment horizon Procter Gamble is expected to generate 7.97 times less return on investment than AN2 Therapeutics. But when comparing it to its historical volatility, Procter Gamble is 4.89 times less risky than AN2 Therapeutics. It trades about 0.08 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 108.00 in AN2 Therapeutics on August 24, 2024 and sell it today you would earn a total of 15.00 from holding AN2 Therapeutics or generate 13.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Procter Gamble vs. AN2 Therapeutics
Performance |
| Timeline |
| Procter Gamble |
| AN2 Therapeutics |
Procter Gamble and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Procter Gamble and AN2 Therapeutics
The main advantage of trading using opposite Procter Gamble and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Procter Gamble vs. Eshallgo Class A | Procter Gamble vs. Amtech Systems | Procter Gamble vs. Gold Fields Ltd | Procter Gamble vs. Aegean Airlines SA |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |